ArticleChemical science2026
Bioinspired pore engineering in two-dimensional covalent organic frameworks.
Article in Chemical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Covalent organic frameworks (COFs) are permanently porous, molecularly engineered scaffolds that exemplify the intersection of design, chemistry, and function. They are composed of organic monomers stitched together by covalent bonds into highly ordered two- or three-dimensional architectures. The majority of the studies on two dimensional COFs have focused on eclipsed rather than antiparallel stacked structures. Drawing inspiration from non-covalent bonding motifs in biomolecules, we report the design and synthesis of robust two-dimensional (2D) COFs with amide side chains called aCOFamide-1 and -2, which mimic the hydrogen bonding motifs found in β-sheets. These linker-based sidechains adopt an antiparallel stacked configuration to create binding sites that display excellent iodine adsorption capability (5.9 g g
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.